BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.16B |
| 2 |
AbbVie
ABBV
|
+$1.93B |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$1.81B |
| 4 |
Otis Worldwide
OTIS
|
+$1.67B |
| 5 |
Carrier Global
CARR
|
+$1.43B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$3.74B |
| 2 |
RTN
Raytheon Company
RTN
|
+$2.93B |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$1.67B |
| 4 |
CY
Cypress Semiconductor
CY
|
+$779M |
| 5 |
iShares MBS ETF
MBB
|
+$772M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.92% |
| 2 | Healthcare | 14.84% |
| 3 | Financials | 12.13% |
| 4 | Consumer Discretionary | 10.93% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Vanguard Total International Bond ETF
BNDX
$82.9B
| $13M | ﹤0.01% |
225,438
-27,991
| -11% | -$1.6M |
|
|
NAGE
3027
Niagen Bioscience
NAGE
$243M
| $13M | ﹤0.01% |
2,827,588
+359,728
| +15% | +$1.61M |
|
|
SJIU
3028
DELISTED
South Jersey Industries, Inc.
SJIU
| $13M | ﹤0.01% |
313,489
+49,828
| +19% | +$2.18M |
|
3029
AXT Inc
AXTI
$4.94B
| $13M | ﹤0.01% |
2,721,079
-87,282
| -3% | -$411K |
|
3030
iShares Biotechnology ETF
IBB
$9.83B
| $12.9M | ﹤0.01% |
+94,518
| New | +$12M |
|
3031
TC Energy
TRP
$67B
| $12.9M | ﹤0.01% |
300,348
+1,080
| +0.4% | +$48.5K |
|
3032
Spero Therapeutics
SPRO
$70.6M
| $12.9M | ﹤0.01% |
950,256
+69,025
| +8% | +$775K |
|
|
CBMG
3033
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
| $12.9M | ﹤0.01% |
858,590
+54,218
| +7% | +$774K |
|
3034
Primis Financial Corp
FRST
$408M
| $12.8M | ﹤0.01% |
1,320,258
+40,137
| +3% | +$386K |
|
3035
CALL
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.4B
| $12.8M | ﹤0.01% |
+200,000
| New | +$11.8M |
|
3036
Greif Class B
GEF.B
$4.23B
| $12.8M | ﹤0.01% |
305,196
-17,706
| -5% | -$693K |
|
3037
Suncor Energy
SU
$74.3B
| $12.8M | ﹤0.01% |
756,726
-888,160
| -54% | -$15.2M |
|
|
ITIC
3038
Investors Title Co
ITIC
$538M
| $12.7M | ﹤0.01% |
104,979
-6,314
| -6% | -$787K |
|
3039
Chunghwa Telecom
CHT
$32.9B
| $12.6M | ﹤0.01% |
320,415
-493
| -0.2% | -$18.2K |
|
|
OTRK
3040
DELISTED
Ontrak
OTRK
| $12.6M | ﹤0.01% |
5,657
+201
| +4% | +$403K |
|
3041
McEwen Inc
MUX
$1.19B
| $12.6M | ﹤0.01% |
1,244,106
+86,209
| +7% | +$801K |
|
3042
OptimizeRx
OPRX
$127M
| $12.6M | ﹤0.01% |
964,229
+28,378
| +3% | +$308K |
|
3043
ACNB Corp
ACNB
$658M
| $12.6M | ﹤0.01% |
479,719
+20,935
| +5% | +$519K |
|
|
MCBC
3044
DELISTED
Macatawa Bank Corp
MCBC
| $12.5M | ﹤0.01% |
1,603,178
+97,176
| +6% | +$703K |
|
|
TAST
3045
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $12.5M | ﹤0.01% |
2,588,027
-92,552
| -3% | -$349K |
|
3046
Alpha Pro Tech
APT
$55.7M
| $12.5M | ﹤0.01% |
707,503
+668,367
| +1,708% | +$9.23M |
|
3047
Distribution Solutions Group
DSGR
$1.61B
| $12.5M | ﹤0.01% |
776,448
+28,648
| +4% | +$453K |
|
|
TPCO
3048
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $12.5M | ﹤0.01% |
1,252,446
-61,159
| -5% | -$548K |
|
|
SIEN
3049
DELISTED
Sientra, Inc.
SIEN
| $12.5M | ﹤0.01% |
323,025
+50,868
| +19% | +$1.53M |
|
|
PCSB
3050
DELISTED
PCSB Financial Corporation
PCSB
| $12.5M | ﹤0.01% |
985,620
-75,090
| -7% | -$979K |
|
Similar funds
BlackRock's Q2 2020 Portfolio in Review
As of Q2 2020, BlackRock held 5,263 positions worth $2.51T, up 23% from $2.04T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2020 filing shows 247 new, 2,443 increased, 1,910 reduced and 215 closed positions. Its largest new stake was Otis Worldwide: 32,136,910 shares worth $1.83B. The largest sale was Allergan plc, an estimated $3.74B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2020 buy was Otis Worldwide: 32,136,910 shares worth $1.83B.
- BlackRock added most to Amazon in Q2 2020, an estimated $2.16B increase.
- BlackRock's biggest Q2 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.67B.
- BlackRock fully exited Allergan plc in Q2 2020, selling an estimated $3.74B.
- BlackRock's ten largest holdings make up 19% of its $2.51T portfolio in Q2 2020.
- BlackRock opened 247 new positions and closed 215 in Q2 2020.
- BlackRock's portfolio value rose 23% quarter-over-quarter to $2.51T.
Based on BlackRock's 13F filing for Q2 2020, filed 14 Aug 2020.